SMAD2 and glioblastoma: In addition, chelerythrine limits the progression of GBM by suppressing the transforming growth factor beta 1 (TGFB1)-ERK1/2/Smad2/3-Snail/zinc-finger E-box binding protein 1 (ZEB1) signaling pathway [40].